1. Home
  2. DDC vs GTBP Comparison

DDC vs GTBP Comparison

Compare DDC & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DDC
  • GTBP
  • Stock Information
  • Founded
  • DDC 2012
  • GTBP 1965
  • Country
  • DDC Hong Kong
  • GTBP United States
  • Employees
  • DDC N/A
  • GTBP N/A
  • Industry
  • DDC Metal Mining
  • GTBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • DDC Basic Materials
  • GTBP Health Care
  • Exchange
  • DDC Nasdaq
  • GTBP Nasdaq
  • Market Cap
  • DDC 6.9M
  • GTBP 6.6M
  • IPO Year
  • DDC 2023
  • GTBP N/A
  • Fundamental
  • Price
  • DDC $0.18
  • GTBP $3.06
  • Analyst Decision
  • DDC Strong Buy
  • GTBP
  • Analyst Count
  • DDC 2
  • GTBP 0
  • Target Price
  • DDC $5.50
  • GTBP N/A
  • AVG Volume (30 Days)
  • DDC 1.7M
  • GTBP 21.7K
  • Earning Date
  • DDC 01-01-0001
  • GTBP 11-14-2024
  • Dividend Yield
  • DDC N/A
  • GTBP N/A
  • EPS Growth
  • DDC N/A
  • GTBP N/A
  • EPS
  • DDC N/A
  • GTBP N/A
  • Revenue
  • DDC $28,978,254.00
  • GTBP N/A
  • Revenue This Year
  • DDC N/A
  • GTBP N/A
  • Revenue Next Year
  • DDC N/A
  • GTBP N/A
  • P/E Ratio
  • DDC N/A
  • GTBP N/A
  • Revenue Growth
  • DDC 14.42
  • GTBP N/A
  • 52 Week Low
  • DDC $0.16
  • GTBP $1.92
  • 52 Week High
  • DDC $6.62
  • GTBP $10.66
  • Technical
  • Relative Strength Index (RSI)
  • DDC 38.97
  • GTBP 55.00
  • Support Level
  • DDC $0.16
  • GTBP $2.73
  • Resistance Level
  • DDC $0.20
  • GTBP $3.20
  • Average True Range (ATR)
  • DDC 0.03
  • GTBP 0.35
  • MACD
  • DDC 0.00
  • GTBP -0.04
  • Stochastic Oscillator
  • DDC 22.50
  • GTBP 42.65

About DDC DDC Enterprise Limited

DDC Enterprise Ltd is a content driven consumer brand offering easy, convenient ready-to-heat , ready-to-cook and plant-based meal products i.e. meal products consisting largely or solely of vegetables, fruits, grains and other foods derived from plant-based protein, rather than animal protein) while promoting healthier lifestyle choices to Millennial and Generation Z customer-base. It is also engaged in the provision of advertising services and the operation of experience stores to offer cooking classes.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: